BFT Financial Group, LLC

SEC CIK: 0001146089
Latest filing: Jul 25, 2023

SEC filings (opens in a new tab)

AVTX holding history

Avalo Therapeutics, Inc. in every 13F filed by BFT Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVTX overview All 13F holders of AVTX Full Q2 2023 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2022

Holdings of AVTX by BFT Financial Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−62,629−100.0%	Sold out	Holders
Q1 2022	62,629	$45.0K	<0.1%	–	No prior filing	Holders